1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The future of intensive care: the study of the microcirculation will help to guide our therapies

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The goal of hemodynamic resuscitation is to optimize the microcirculation of organs to meet their oxygen and metabolic needs. Clinicians are currently blind to what is happening in the microcirculation of organs, which prevents them from achieving an additional degree of individualization of the hemodynamic resuscitation at tissue level. Indeed, clinicians never know whether optimization of the microcirculation and tissue oxygenation is actually achieved after macrovascular hemodynamic optimization. The challenge for the future is to have noninvasive, easy-to-use equipment that allows reliable assessment and immediate quantitative analysis of the microcirculation at the bedside. There are different methods for assessing the microcirculation at the bedside; all have strengths and challenges. The use of automated analysis and the future possibility of introducing artificial intelligence into analysis software could eliminate observer bias and provide guidance on microvascular-targeted treatment options. In addition, to gain caregiver confidence and support for the need to monitor the microcirculation, it is necessary to demonstrate that incorporating microcirculation analysis into the reasoning guiding hemodynamic resuscitation prevents organ dysfunction and improves the outcome of critically ill patients.

          Related collections

          Most cited references70

          • Record: found
          • Abstract: found
          • Article: not found

          The retina as a window to the brain-from eye research to CNS disorders.

          Philosophers defined the eye as a window to the soul long before scientists addressed this cliché to determine its scientific basis and clinical relevance. Anatomically and developmentally, the retina is known as an extension of the CNS; it consists of retinal ganglion cells, the axons of which form the optic nerve, whose fibres are, in effect, CNS axons. The eye has unique physical structures and a local array of surface molecules and cytokines, and is host to specialized immune responses similar to those in the brain and spinal cord. Several well-defined neurodegenerative conditions that affect the brain and spinal cord have manifestations in the eye, and ocular symptoms often precede conventional diagnosis of such CNS disorders. Furthermore, various eye-specific pathologies share characteristics of other CNS pathologies. In this Review, we summarize data that support examination of the eye as a noninvasive approach to the diagnosis of select CNS diseases, and the use of the eye as a valuable model to study the CNS. Translation of eye research to CNS disease, and deciphering the role of immune cells in these two systems, could improve our understanding and, potentially, the treatment of neurodegenerative disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock

            Abnormal peripheral perfusion after septic shock resuscitation has been associated with organ dysfunction and mortality. The potential role of the clinical assessment of peripheral perfusion as a target during resuscitation in early septic shock has not been established.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

              Activation of the coagulation system and depletion of endogenous anticoagulants are frequently found in patients with severe sepsis and septic shock. Diffuse microthrombus formation may induce organ dysfunction and lead to excess mortality in septic shock. Antithrombin III may provide protection from multiorgan failure and improve survival in severely ill patients. To determine if high-dose antithrombin III (administered within 6 hours of onset) would provide a survival advantage in patients with severe sepsis and septic shock. Double-blind, placebo-controlled, multicenter phase 3 clinical trial in patients with severe sepsis (the KyberSept Trial) was conducted from March 1997 through January 2000. A total of 2314 adult patients were randomized into 2 equal groups of 1157 to receive either intravenous antithrombin III (30 000 IU in total over 4 days) or a placebo (1% human albumin). All-cause mortality 28 days after initiation of study medication. Overall mortality at 28 days in the antithrombin III treatment group was 38.9% vs 38.7% in the placebo group (P =.94). Secondary end points, including mortality at 56 and 90 days and survival time in the intensive care unit, did not differ between the antithrombin III and placebo groups. In the subgroup of patients who did not receive concomitant heparin during the 4-day treatment phase (n = 698), the 28-day mortality was nonsignificantly lower in the antithrombin III group (37.8%) than in the placebo group (43.6%) (P =.08). This trend became significant after 90 days (n = 686; 44.9% for antithrombin III group vs 52.5% for placebo group; P =.03). In patients receiving antithrombin III and concomitant heparin, a significantly increased bleeding incidence was observed (23.8% for antithrombin III group vs 13.5% for placebo group; P<.001). High-dose antithrombin III therapy had no effect on 28-day all-cause mortality in adult patients with severe sepsis and septic shock when administered within 6 hours after the onset. High-dose antithrombin III was associated with an increased risk of hemorrhage when administered with heparin. There was some evidence to suggest a treatment benefit of antithrombin III in the subgroup of patients not receiving concomitant heparin.
                Bookmark

                Author and article information

                Contributors
                Jacques.duranteau@aphp.fr
                Journal
                Crit Care
                Critical Care
                BioMed Central (London )
                1364-8535
                1466-609X
                16 May 2023
                16 May 2023
                2023
                : 27
                : 190
                Affiliations
                [1 ]GRID grid.460789.4, ISNI 0000 0004 4910 6535, Department of Anesthesiology and Intensive Care, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), INSERM UMR-S 999, , Paris-Saclay University, ; Le Kremlin-Bicêtre, France
                [2 ]GRID grid.4989.c, ISNI 0000 0001 2348 0746, Department of Intensive Care, CHIREC Hospitals, , Université Libre de Bruxelles, ; Boulevard du Triomphe 201, 1160 Brussels, Belgium
                [3 ]GRID grid.5611.3, ISNI 0000 0004 1763 1124, Anaesthesia and Intensive Care Unit B, Department of Surgery, Dentistry, Paediatrics and Gynaecology, , University of Verona, University Hospital Integrated Trust of Verona, ; Verona, Italy
                [4 ]GRID grid.38142.3c, ISNI 000000041936754X, Department of Emergency Medicine, , Beth Israel Deaconess Medical Center–Harvard Medical School, ; Boston, MA USA
                [5 ]GRID grid.429705.d, ISNI 0000 0004 0489 4320, King’s College Hospital NHS Foundation Trust, ; London, UK
                [6 ]GRID grid.415490.d, ISNI 0000 0001 2177 007X, Academic Department of Military Anaesthesia and Critical Care, , Royal Centre for Defence Medicine, ; Birmingham, UK
                [7 ]GRID grid.16149.3b, ISNI 0000 0004 0551 4246, Division of General Internal and Emergency Medicine, Nephrology, and Rheumatology, Department of Medicine D, , University Hospital Münster, ; Albert-Schweitzer-Campus 1, 48149 Münster, Germany
                [8 ]GRID grid.266102.1, ISNI 0000 0001 2297 6811, Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care, , UCSF, ; San Francisco, USA
                [9 ]GRID grid.5645.2, ISNI 000000040459992X, Department of Intensive Care, Erasmus MC, , University Medical Center, ; Rotterdam, The Netherlands
                Article
                4474
                10.1186/s13054-023-04474-x
                10186296
                37193993
                d2168c16-25c3-4aad-be76-e1edd4f426fa
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 16 February 2023
                : 3 May 2023
                Categories
                Review
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2023

                Emergency medicine & Trauma
                hemodynamic resuscitation,microcirculation,icu,hand-held vital microscopes,artificial intelligence

                Comments

                Comment on this article